ImageneBio Inc.
Organization details
- Legal name
- ImageneBio Inc.
- Former names
- Ikena Oncology, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- SAN Diego
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- IMA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001835579
- EIN
- 81-1697316
Board of directors
-
David P. Bonita · DirectorSince 2023
-
Iain D. Dukes · DirectorSince 2023
-
Jean Francois Formela · DirectorSince 2023
-
Jonathan Jian Wang · DirectorSince 2025
-
Joseph P. Slattery · DirectorSince 2025
-
Kristin Yarema · Director · Chief Executive OfficerSince 2025
-
Maria Koehler · DirectorSince 2023
-
Mark Manfredi · Director · President & CEOSince 2023
-
Otello Stampacchia · DirectorSince 2023
-
Owen Hughes · DirectorSince 2023
-
Richard Wooster · DirectorSince 2023
-
Stephen Hui Wang · DirectorSince 2025
-
Wei-guo Su · DirectorSince 2026
Chief executives
Weak · grade F
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 0
-77.1% a year in revenue
20% of the scoring weight is on file. Figures cover December 2024 – December 2025.
Director election results
Annual meeting of June 16, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
99.4%
-
99.5%
Board connections
6 of this board's directors also sit on 9 other boards. 9 are in the same sector.
-
AnaptysBio Inc. Same sectorvia Owen Hughes
-
C4 Therapeutics Inc. Same sectorvia Owen Hughes
-
CVRx Inc. Same sectorvia Joseph P. Slattery
-
HUTCHMED (China) Limited Same sectorvia Wei-guo Su
-
Iovance Biotherapeutics Inc. Same sectorvia Iain D. Dukes
-
Korro Bio Inc. Same sectorvia Jean Francois Formela
-
Prelude Therapeutics Incorporated Same sectorvia David P. Bonita
-
Replimune Group Inc. Same sectorvia Joseph P. Slattery
-
Traws Pharma Inc. Same sectorvia Iain D. Dukes
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $95,840
- 1 purchase by 1 insider
- Sold, last 12 months
- $17,334
- 2 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 14, 2026 | Grant-Huerta Yanina Officer (Chief Financial Officer) | Grant or award | +65,000 | — | — |
| Aug 14, 2026 | Kristin Yarema Director, Officer (Chief Executive Officer) | Grant or award | +254,800 | — | — |
| Aug 14, 2026 | Grant-Huerta Yanina Officer (Chief Financial Officer) | Grant or award | +39,000 | — | — |
| Jul 25, 2026 | Kristin Yarema Director, Officer (Chief Executive Officer) | Option exercise | +38,376 | — | — |
| Jul 25, 2026 | Kristin Yarema Director, Officer (Chief Executive Officer) | Other | +115,129 | — | — |
| Jul 17, 2026 | Lally Robert B Officer (Principal Accounting Officer) | Open-market sale | −1,525 | $5.34 | $8,144 |
| Jul 16, 2026 | Lally Robert B Officer (Principal Accounting Officer) | Open-market sale | −1,671 | $5.50 | $9,191 |
| Mar 16, 2026 | Kristin Yarema Director, Officer (Chief Executive Officer) | Grant or award | +85,400 | — | — |
| Dec 30, 2025 | Butler Erin Officer (Principal Accounting Officer) | Grant or award | +22,500 | — | — |
| Dec 24, 2025 | Joseph P. Slattery Director | Open-market purchase | +16,000 | $5.99 | $95,840 |
| Jul 28, 2025 | Marango Jotin Officer (Chief Financial Officer) | Grant or award | +15,776 | — | — |
| Jul 28, 2025 | Marango Jotin Officer (Chief Financial Officer) | Shares withheld for tax | −4,630 | $17.16 | $79,451 |
| Jul 25, 2025 | Jonathan Jian Wang Director | Grant or award | +143,832 | — | — |
| Jul 25, 2025 | ORBIMED ADVISORS LLC Director | Grant or award | +83,611 | $2.49 | $208,191 |
| Jul 25, 2025 | David P. Bonita Director | Option exercise | +379 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about ImageneBio Inc.
Who is the CEO of ImageneBio Inc.?
Kristin Yarema has been ImageneBio Inc.'s Chief Executive Officer since July 2025.
How many directors are on ImageneBio Inc.'s board?
ImageneBio Inc.'s board has 13 directors: David P. Bonita, Iain D. Dukes, Jean Francois Formela, Jonathan Jian Wang, Joseph P. Slattery, Kristin Yarema, Maria Koehler, Mark Manfredi, Otello Stampacchia, Owen Hughes and 3 others.
Are ImageneBio Inc. insiders buying or selling shares?
Over the last 12 months, ImageneBio Inc. insiders bought $95,840 of shares in 1 purchase and sold $17,334 of shares in 2 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="imagenebio-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.